From 1 June 2022, the heel prick test for Dutch newborns will also screen for spinal muscular atrophy (SMA). SMA is a serious hereditary muscle condition. Detecting this disease at an early stage enables early treatment.
Promising biobased alternatives to controversial polar aprotic solvents
There are a number of promising biobased alternatives to controversial polar aprotic solvents, as revealed in a report from Wageningen Food & Biobased Research commissioned by RIVM .
Blood spot test extended as of 1 January 2017 to include two more disorders
As of 1 January 2017, the disorders alpha and beta thalassaemia will be added to the neonatal blood spot (‘heel prick’) screening programme.
Newborn heel prick screening starts on St Eustatius and Saba
On 26 October 2015, heel prick screening started for all newborns on St Eustatius and Saba.
RIVM seeks dialogue with Industry for safe and green chemistry
RIVM would like to explore possibilities to eliminate obstacles during innovation of green chemistry with industry.
Biobased alternatives to hormone disrupting substance in cash register receipts
Chemicals made from vegetable or animal waste may be an alternative to the use of the substance Bisphenol A (BPA) in thermal paper. Thermal paper is widely used for cash register receipts.